Northwest Eye Clinical Research Update: The Glaukos iDose GC-012 Study

iDose GC-012 Study,Provider Newsletter,Uncategorized

  Study Overview Northwest Eye Surgeons is happy to announce that Drs. Cameron and Kuzin are Principal Investigators in an active FDA approved Phase III clinical study on iDose Travoprost Intraocular Implants.  This is a prospective, randomized masked three year study comparing novel implantable glaucoma medication delivery devices to topical timolol.  One of two biocompatible…

Read More

Angle Closure

Glaucoma,Provider Newsletter,Uncategorized

According to the World Health Organization, glaucoma is the leading cause of preventable blindness worldwide. Glaucoma can be subdivided into two types based on anterior segment anatomy: open-angle glaucoma or angle-closure glaucoma. While open-angle glaucoma is the significantly more prevalent form of the two, angle-closure glaucoma is more likely to cause bilateral blindness. Angle closure…

Read More